Sponsor:
Mayo Clinic
Code:
NCT07805083
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Educational Cancer Intervention
ICF Text Version 1
ICF Text Version 2
ICF Video Version 1
ICF Video Version 2
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT07805083
Start date
Jul 21, 2026
Status verified date
Sep, 2026
Completion date
Jul 20, 2029
Anticipated
Primary completion date
Jul 20, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
600 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Health Services Research
Arms
experimental: Arm I - ICF Text Version 1
experimental: Arm II - ICF Text Version 2
experimental: Arm III - ICF Video Version 1
experimental: Arm IV - ICF Video Version 2
experimental: Arm V - ICF Video Version 3
experimental: Arm VI - ICF Video Version 4
Interventions
Educational Cancer Intervention
ICF Text Version 1
ICF Text Version 2
ICF Video Version 1
ICF Video Version 2
ICF Video Version 3
ICF Video Version 4
Survey Administration
Primary outcome measure
Central contacts
Locations
Mayo Clinic in Florida
Recruiting
Jacksonville, Florida, United States, 32224-9980
Contacts
Principal Investigator:
Janice L. Krieger, PhD
Sponsor
Mayo Clinic
Last update posted
Sep 8, 2026
Last verified
Sep, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-09-08.